20/20 Biolabs (AIDX) Trading Performance
20/20 Biolabs (ticker AIDX) closed the trading day on Thursday, 22 September 2026, at a price that was 3.85 % higher than the previous close. The last recorded price was USD 0.27, available on major exchanges. At the close, the company had an outstanding share count of 12.8 million and a market capitalization of USD 3.3 million.
In the preceding 24 hours, the trading volume totaled approximately USD 40.9 thousand. Over the last month, the stock has declined by 42.55 %. The 200‑day simple moving average is USD 1.41. The all‑time high for the past 52 weeks was USD 50, reached on 19 February 2026; the 52‑week low was USD 0.26 on 20 October 2026.
Trading Metrics
| Metric | Value |
|---|---|
| Current price | USD 0.27 |
| Shares outstanding | 12.8 million |
| Market capitalization | USD 3.3 million |
| 24‑hour volume | USD 40.9 k |
| 24‑hour change | +3.85 % |
| Monthly change | –42.55 % |
| 200‑day SMA | USD 1.41 |
| 52‑week high | USD 50 |
| 52‑week low | USD 0.26 |
Performance of Related Stocks (24‑Hour Period)
| Company | Ticker | 24‑hour change | Current price | Market capitalization |
|---|---|---|---|---|
| Kala Bio | KALA | –1.55 % | USD 0.19 | USD 3.7 million |
| Cadrenal Therapeutics | CVKD | –1.89 % | USD 1.02 | USD 3.8 million |
| Pharmacyte Biotech | PMCB | +0.06 % | USD 0.35 | USD 3.7 million |
| Cbdmd | YCBD | +11.21 % | USD 0.38 | USD 3.9 million |
| Senestech | SNES | –1.57 % | USD 0.75 | USD 3.8 million |
These figures provide a snapshot of the recent trading activity and valuation metrics for 20/20 Biolabs and its peer companies within the biotechnology sector.
